ANAL CANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL CANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL CANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL CANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less be more? new study tests gentler treatment for anal cancer
Disease control OngoingThis study is for people with early-stage anal cancer. It compares a lower-dose chemotherapy and radiation treatment to the standard dose. The goal is to see if the lower dose works just as well to control the cancer but causes fewer side effects and improves quality of life. Abo…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
Immunotherapy combo shows promise for tough anal cancer
Disease control OngoingThis study tests two immunotherapy drugs, nivolumab and ipilimumab, in people with anal cancer that has spread and not responded to prior treatment. The goal is to see if these drugs can shrink tumors or slow cancer growth. About 143 participants will receive either nivolumab alo…
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Scientists track Cancer's genetic shifts during therapy in new study
Knowledge-focused OngoingThis study looks at how certain cancers (head and neck, esophagus, and anal canal) change at the genetic and immune level when patients receive chemotherapy or immunotherapy. Researchers collect blood and tumor samples before and during treatment to track these changes. The goal …
Matched conditions: ANAL CANAL SQUAMOUS CELL CARCINOMA
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC